Nathan Hambly

Division of Respirology

Nathan Hambly

Assistant Professor, Division of Respirology, Department of Medicine

 

 

 

 

 

 

Education and Professional Standing

Dr. Nathan Hambly earned his medical degree at the University of Ottawa (2009) and completed both Internal Medicine (2012) and Adult Respirology (2014) residencies at McMaster University.  He has since fulfilled Clinical Fellowships in Pulmonary Hypertension and Interstitial Lung Disease at McMaster University, the University of Toronto, and the Royal Brompton Hospital, London, United Kingdom.  Dr. Hambly is now an Assistant Professor in the Department of Medicine at McMaster University.  He is the Clinical Lead of the Firestone Institute Pulmonary Hypertension Program at St. Joseph’s Hospital and McMaster University and works as a Consultant Respirologist at St. Joseph’s Healthcare Hamilton.  His clinical interests include pulmonary hypertension, interstitial lung disease, and sarcoidosis.

Research Interests

  • Pulmonary Hypertension
  • Interstitial Lung Disease
  • Sarcoidosis
  • Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Selected Publications

  1. Hambly N, Mehta S. Pulmonary hypertension: new frontiers. CMAJ. (Forthcoming in 2016).
  2. Hambly N, Granton J. Riociguat for the treatment of pulmonary hypertension. Expert Rev Respir Med.  2015; 9:679-95.
  3. Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M. The Canadian redistry for pulmonary fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registry. Can Respir J. (2015) pii: 17206 [Epub ahead of print].
  4. Hambly N, Shimbori C, and Kolb M. Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers. Respirology. (2015) Jun 24. doi: 10.1111/resp.12569
  5. Ask K, Hambly N, and Kolb M.  Biomarkers in interstitial lung disease: Moving towards composite indexes and multimarkers.  Curr Respir Care Rep. (2015); 4(3): 125-129.
  6. Hambly N, Nair P.  Monoclonal antibodies in the treatment of refractory asthma.  Curr Opin Pulm Med (2014); Jan;20(1):87-94. 
  7. Hambly N, Sekhon S, McIvor A. Antiphospholipid Antibody Syndrome: Diffuse Alveolar Hemorrhage and Libman-Sacks Endocarditis in the Absence of Prior Thrombotic Events. Ulster Med J (2014);83(1): 47-49.
  8. Hambly N, McIvor A. Chronic obstructive pulmonary disease: managing acute exacerbations. Student BMJ 2013; 21:f6151.
  9. Hambly N, McIvor A. Chronic obstructive pulmonary disease: long term management. Student BMJ 2013; 21:f5043